The inhibition of histone deacetylase activity is known to induce morphological changes of transformed cells. In this study, we investigated the effect of the specific HDAC inhibitor, trichostatin A (TSA), on colon carcinoma cell lines. Treatment of human colorectal carcinoma cells, KM1214 and KM12SM, with TSA induced distinct morphological changes. Both cell lines, which normally piled up in layers without clear boundary, became more flattened, and formed monolayers with evident boundaries between cells, with concomitant increased actin filament organization. Cell-cell interaction was not affected much, based on expression level, membrane localization, and interaction of E-cadherin with b-catenin. In contrast, syndecan-2 expression was dramatically reduced and it was correlated with the morphological changes of colon carcinoma cells. Consistently, downregulation of syndecan-2 expression by antisense cDNA clearly mimicked the morphological changes in KM12SM and reduced anchorage-independent growth of colon cancer cells. All these results indicate that reduced syndecan-2 expression correlates with TSA-induced morphological changes and reduced tumorigenic activity in colon carcinoma cells.
The inhibition of histone deacetylase activity is known to induce morphological changes of transformed cells. In this study, we investigated the effect of the specific HDAC inhibitor, trichostatin A (TSA), on colon carcinoma cell lines. Treatment of human colorectal carcinoma cells, KM1214 and KM12SM, with TSA induced distinct morphological changes. Both cell lines, which normally piled up in layers without clear boundary, became more flattened, and formed monolayers with evident boundaries between cells, with concomitant increased actin filament organization. Cell-cell interaction was not affected much, based on expression level, membrane localization, and interaction of E-cadherin with b-catenin. In contrast, syndecan-2 expression was dramatically reduced and it was correlated with the morphological changes of colon carcinoma cells. Consistently, downregulation of syndecan-2 expression by antisense cDNA clearly mimicked the morphological changes in KM12SM and reduced anchorage-independent growth of colon cancer cells. All these results indicate that reduced syndecan-2 expression correlates with TSA-induced morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene (2003 Oncogene ( ) 22, 826-830. doi:10.1038 Keywords: colon carcinoma; histone deacetylase syndecan-2; tumorigenesis Modulation of gene expression is affected by chromatin structure changes (Sealy and Chalkley, 1978; Struhl, 1998) . One well-characterized mechanism is through histone acetylation. Histone acetylation is regulated by two enzymes, histone acetyl transferase (HAT) and histone deacetylase (HDAC) (Cress and Seto, 2000; Marks et al., 2001) . Interestingly, inhibition of HDAC activity using HDAC inhibitors, which results in the accumulation of highly acetylated histone, causes morphological changes of v-src and v-Haras-transformed cells into nontransformed phenotype (Kwon et al., 1998; Hoshikawa et al., 1994) . Similarly, trichostatin A (TSA), which is a potent and specific inhibitor of HDAC activity (Yoshida et al., 1990; Sugita et al., 1992) , induces dramatic morphological changes in human carcinoma cell lines such as the T24 urinary bladder cell line and HeLa (Hoshikawa et al., 1994) .
TSA also induced morphological changes in colon cancer cell lines. TSA was treated at different metastatic stages of colon cancer cell lines including mild metastatic (COLO205, SW403, and LOVO) and highly metastatic cells (KM1214, KM12SM, and HCT116). Cell morphology was monitored by phase contrast microscopy. Among six different cell lines, highly metastatic KM 1214 and KM12SM, but not others, showed a dramatic morphological changes by the TSA treatment (Figure 1a) , along with increased histone acetylation (data not shown). In normal culture conditions, those cells showed aggregated cell morphology with no clear boundary between cells with cells piled up in layers even at low cell density. In contrast, KM12SM and KM1214 treated with 330 nm TSA, became more flattened with epithelial morphology and clear cell-cell margins. Even at high cell density, no cells grew in multilayers after TSA treatment. Consistent with the morphological change, TSA induced the organization of actin filaments into bundles, which was much less in KM12SM cells (Figure 1b) . TSA-induced morphological changes were most evident at 24 h and maintained up to 36 h (data not shown).
The clear boundary implied that TSA-induced morphological changes might be because of altered cell-cell adhesion. Therefore, the expression levels of E-cadherin and b-catenin were analyzed by Western blotting using specific antibodies (Figure 2a ). Despite clear morphological changes, KM12SM levels of E-cadherin and b-catenin were unchanged with TSA treatment. Similarly, immunohistochemical studies showed that E-cadherin in KM12SM cells predominantly localized into cell surface in both independently growing monolayer cells and aggregated multilayer cells. Even after TSA treatment, KM12SM also showed a similar staining pattern of E-cadherin around cell surface ( Figure 2b ). These clearly demonstrated that TSA affected neither the expression nor the localization of both E-cadherin and b-catenin. There was no significant (Figure 2c ). Since it has been shown that breast tumor cells express increased N-cadherin (Rachel et al., 2000) , it was possible that tumorigenic activity of colon cancer cells may be regulated through increased expression of N-cadherin. In turn, N-cadherin expression in KM12SM might be sensitive to TSA treatment. However, N-cadherin mRNA levels were unchanged (Figure 2d ). Therefore, it is not likely that cell-cell interaction was greatly influenced by TSA treatment. We next investigated the expression of cell-ECM adhesion receptors. Integrin b1 expression was analyzed by both RT-PCR and Western blotting with a specific antibody (Figure 3a) . Levels of both mRNA and protein were slightly and transiently increased in response to TSA treatment. However, there were dramatic changes in the expression of syndecans, which are coreceptors for integrins (Couchman and Woods, 1999; Zimmermann and David, 1999; Rapraeger, 2000; Woods and Couchman, 2000) . Compared with other syndecans, syndecan-2 was highly expressed in KM12SM, while TSA dramatically decreased mRNA expression of syndecan-2 in a time-dependent manner. In contrast, both syndecan-1 and -4 expressions were lower in KM12SM, and its expression was slightly increased by TSA (Figure 3b) . The decrease in cell surface expression of syndecan-2 was evident on detection with antisyndecan-2 antibody in TSA-incubated KM12SM cells (Figure 3c) . Interestingly, consistent with the morphological changes, mRNA expressions of syndecan-2 were decreased only in KM1214 and KM12SM, but not in others (Figure 3d ). In addition, TSA increased expression of syndecan-1 without the morphological changes in Lovo and SW403 cell lines, and its expression was not detected in Colo205 and HCT116 cell lines (Figure 3d) . Therefore, decreased expression of syndecan-2, but not syndecan-1, is correlated with the morphological changes of colon carcinoma cells. /ml) were incubated with anti-syndecan-2 in 10% FBS in PBS for 1 h on 41C. This was followed by PBS, containing 0.05% Tween-20, washing three times and incubating FITC-conjugated antichicken in 10% FBS in PBS for 30 min. Syndecan-2 cell surface expressions were analyzed by flow cytometry. IgG was used as a control. (d) After treatment with TSA for the indicated period of time, both syndecan-1 and -2 mRNA expressions were analyzed by RT-PCR in colon carcinoma cell lines as described above. GAPDH was used as a control
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It has been known that expressions of syndecan-1 and -4 are reduced in colon carcinoma cells compared to adenoma (Jayson et al., 1999) , and syndecan-2 may function as an adhesion receptor in Lewis lung carcinoma (Kusano et al., 2000) . These reports prompted us to investigate the function of syndecan-2 on the morphology of colon cancer cells. Instead of TSA, we reduced expression of syndecan-2 using antisense cDNA in KM12SM cell lines (Figure 4a) . At 72 h after transfection, we could observe the clear morphological changes (Figure 4b ). Similar to TSAinduced cell morphology, most of the cells obtained clear cell boundary, flattened morphology, and reappearance of actin filament (data not shown). This result indicates that reduction of syndecan-2 expression is enough to induce TSA-induced morphological changes. Thus, reduced expression of syndecan-2 was the cause of morphological change of colon cancer cells. Besides, antisense syndecan-2-transfected cells significantly reduced anchorage-independent cell growth ( Figure 4c ). Compared with control cells (100%), the number of colonies formed in soft agar clearly decreased in both TSA-treated cells (16.0%) and antisense syndecan-2 cDNA transfected cells (3.6%), implying reduced tumorigenic activity. Taken together, these data demonstrate that syndecan-2 expression is closely related with both cell morphology and tumorigenic activity in colon cancer cells.
In general, syndecans are known to suppress tumor formation and their expressions are downregulated in transformed/cancer cells (Bernfield et al., 1992; Leppa et al., 1992; Inki and Jalkanen, 1996, Jayson et al., 1999; Wiksten et al., 2001 ). However, this study clearly shows that syndecan-2 expression is important for tumor formation in colon carcinoma cells, since (1) expression of syndecan-2 was increased compared to syndecan-1 and -4 (Figure 3) , and (2) decreased syndecan-2 expression by either TSA treatment or antisense syndecan-2 cDNA induced the morphological change and reduced tumorigenic activity (Figure 4) . Therefore, syndecan-2 expression is critical for tumorigenic morphology and activity in colon cancer cells. Syndecan-2 appears to be transcriptionally regulated by an unknown mechanism associated with histone acetylation. Further studies are required to elucidate the critical factors, together with syndecan-2, for understanding the precise mechanism in TSA-induced morphological changes and tumorigenesis in colon cancer cells. 7 of KM12SM were transfected using effectene with 4 mg of syndecan-2 antisense cDNA in pcDNA 3.1 and analyzed by FACS using anti-syndecan-2 antibody, followed by fluorescein isothiocyanate-conjugated anti-chicken IgY. (b) After 3 days of selection in the presence of 0.2 mg/ml of G418, morphological changes were monitored and photographs were taken under a phase-contrast microscope attached with a digital camera. (c) Either 330 nM TSA-treated or nontreated KM12SM cells (left panel) and either 4 mg of empty vector or antisense cDNA syndecan-2 transfected KM12SM cells (right panel) were seeded in soft agar at a density of 1 Â 10 cells/dish and allowed to grow for 14 days. Viable colonies were counted. Each experiment was performed in triplicate TSA-induced morphological changes Y Kim et al
